Evidence map›Paper›PMID 38450376›Full record

ArticleFrontiers in cardiovascular medicine2024

Intravascular lithotripsy (IVL) enabled the percutaneous closure of a severely calcified paravalvular leak regurgitation following implantation of a self-expandable transcatheter aortic valve: a case report.

Salvatore Evola, Alessandro D'Agostino, Daniele Adorno, Oreste Fabio Triolo, Gioacchino Giarratana, Sebastiano Castrovinci, Vincenzo Argano, Eustaquio Maria Onorato

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Salvatore EvolaCatheterization Laboratory, Department of Medicine and Cardiology, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Alessandro D'AgostinoCatheterization Laboratory, Department of Medicine and Cardiology, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Daniele AdornoCatheterization Laboratory, Department of Medicine and Cardiology, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Oreste Fabio TrioloCatheterization Laboratory, Department of Medicine and Cardiology, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Gioacchino GiarratanaU.O.C. Cardiochirurgia, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Sebastiano CastrovinciU.O.C. Cardiochirurgia, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Vincenzo ArganoU.O.C. Cardiochirurgia, Azienda Ospedaliera Universitaria Policlinico "P. Giaccone", Palermo, Italy.
Eustaquio Maria OnoratoUniversity Cardiology Department, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITIstituto Clinico Sant'Ambrogio · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Closure of paravalvular leak (PVL) regurgitation after self-expandable (SE) transcatheter aortic valve implantation (TAVI) may be more challenging than after balloon-expandable (BE) valve implantation. Case summary: An 85-year-old woman suffering from long-standing atrial fibrillation and severe symptomatic aortic stenosis underwent SE TAVI (26 mm Evolut™ R®, Medtronic Inc., MN, USA). A total of eighteen months after TAVI she was admitted for congestive heart failure and two-dimensional (2D) transesophageal echocardiography (TEE) color Doppler showed moderate-severe PVL regurgitation due to a long and heavily calcified leak located below the left coronary sinus. The patient was deemed to be at prohibitive surgical risk and a catheter-based PVL closure procedure was planned. A first attempt to cross the PVL from the femoral artery was unsuccessful due to an inappropriate angle between the catheter and the entry site of this hard-to-approach calcified leak. A Terumo hydrophilic guidewire 0.35 inch-260 cm from the right radial artery was then successfully advanced across the leak to the left ventricle (LV); however, of most of the catheters used, only a Glidecath 4-Fr could cross the leak over the hydrophilic wire. The hydrophilic guidewire was replaced with a stiffer guidewire that, after creating a loop in the LV, was advanced across the self-expandable valve into the descending aorta where it was snared and externalized through the left femoral artery, thus creating an arterio-arterial (AA) loop. A 6-Fr Multipurpose guiding catheter was advanced over the exchange wire and the leak was crossed with an additional 0.0014 coronary guidewire (PILOT, Abbott Vascular), predilated with two non-compliant balloon dilatation catheters, and finally, the PVL was engaged with a 3.0 mm × 12 mm Shockwave balloon (Shockwave Medical Inc, Santa Clara, California, USA). Intravascular lithotripsy (IVL) application to this highly calcified leak and the increased support provided by the stiff guidewire finally allowed the progression of the 6-Fr dedicated delivery sheath (ODS III) into the LV. A 5 mm square twist (ST) device (PLD, Occlutech, Helsingborg, Sweden) was successfully deployed within the leak and the final echocardiographic and angiographic control confirmed the effective PVL closure. Discussion: In patients at high surgical risk with moderate to severe regurgitation after SE TAVI due to a hard-to-approach calcified long tract, an extra AA support loop is mandatory during percutaneous PVL closure. Furthermore, IVL application greatly facilitates the progression of the delivery sheath and occluder which is key to a successful procedure.

Indexed as

calcified paravalvular leakintravascular lithotripsyparavalvular leak closureparavalvular leak regurgitationself-expandable transcatheter aortic valve implantation

Identifiers

PMID38450376
PMCPMC10914981
OpenAlexW4392003023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.